{"id":511691,"date":"2020-10-14T16:08:01","date_gmt":"2020-10-14T16:08:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=511691"},"modified":"2020-10-14T16:08:01","modified_gmt":"2020-10-14T16:08:01","slug":"global-ophthalmology-drugs-market-value-expected-to-reach-5369887-million-by-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-ophthalmology-drugs-market-value-expected-to-reach-5369887-million-by-2030_511691.html","title":{"rendered":"Global Ophthalmology Drugs Market Value Expected To Reach $53,698.87 Million By 2030"},"content":{"rendered":"
\"Global<\/a><\/p>\n
\n
Ophthalmology Drugs Market – By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies\/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies \u2013 Global Forecast To 2030<\/div>\n<\/div>\n<\/div>\n
Novartis Is One Of The Largest Players In The Ophthalmology Drugs Market, According To The Business Research Company\u2019s Ophthalmology Drugs Market – By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies\/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), And, By Region, Opportunities And Strategies \u2013 Global Forecast To 2030<\/div>\n

The global ophthalmology drugs market is expected to decline from $24,640.0 million in 2019 to $19,831.3 million in 2020 at a compound annual growth rate of -19.5%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a compound annual growth rate of 44.6% from 2021 and reach $33,272.8 million in 2023. The market is expected to grow at a compound annual growth rate of 7.2% to nearly $38,223.53 million by 2025, and at a compound annual growth rate of 7.0% to $53,698.87 million by 2030. <\/p>\n

Read More On The Global Ophthalmology Drugs Market Report At –<\/strong>https:\/\/www.thebusinessresearchcompany.com\/report\/ophthalmology-drugs-market<\/a><\/p>\n

The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases.<\/p>\n

Global Ophthalmology Drugs Market Segmentation –
<\/strong>1) By Drug Type-<\/strong> Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmology Drugs.
2) By Prescription Type-<\/strong> OTC Drugs, Prescription Drugs.
3) By Distribution Channel-<\/strong> Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies.<\/p>\n

Global Ophthalmology Drugs Market Driver –
<\/strong>Increasing incidence and prevalence of eye diseases causing vision loss or blindness and age-related eye diseases is expected to support the growth of the ophthalmic drugs market. Eye disorders such as age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and cataract are becoming major causes of visual impairment and blindness globally.<\/p>\n

Request For A Sample Of The Global Ophthalmology Drugs Market Report At –<\/strong>https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=2142&type=smp<\/a><\/p>\n

Few Points From The Global Ophthalmology Drugs Market TOC
<\/strong>1. Ophthalmology Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1.1. Segmentation By Geographyes, Online Pharmacies.
7. Ophthalmology Drugs Market Characteristics
7.1. Market Definition
8. Ophthalmology Drugs Market Product Analysis – Product Examples
8.1. Leading Products
9. Ophthalmology Drugs Market Supply Chain Analysis
9.1. Raw Material Suppliers
9.2. Contract Research Organization (CRO)<\/p>\n

Interested to know more about The Business Research Company?
<\/strong>The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> The Business Research Company<\/a>
Contact Person:<\/strong> Oliver Guirdham
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +44 20 7193 0708
Address:<\/strong>
City:<\/strong> London
State:<\/strong> Greater London
Country:<\/strong> United Kingdom
Website:<\/strong> https:\/\/www.thebusinessresearchcompany.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Ophthalmology Drugs Market – By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies\/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[450,405,406,403,404],"tags":[],"class_list":["post-511691","post","type-post","status-publish","format-standard","hentry","category-Australia","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/511691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=511691"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/511691\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=511691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=511691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=511691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}